Review of anti-obesity medications by Iowa's health and administrative services departments for medical assistance and public employee health plans.

The bill mandates the Department of Health and Human Services and the Department of Administrative Services to review anti-obesity medications, including GLP-1 agonists, for their effectiveness in weight loss, impact on comorbidities, potential cost savings, and recommended eligibility requirements. The departments must submit a report to the general assembly by January 5, 2026, detailing their findings and proposed eligibility requirements for the medical assistance program and health insurance plans for public employees.

Review of anti-obesity medications by Iowa's health and administrative services departments for medical assistance and public employee health plans.

The bill mandates the Department of Health and Human Services and the Department of Administrative Services to review anti-obesity medications, including GLP-1 agonists, for their effectiveness in weight loss, impact on comorbidities, potential cost savings, and recommended eligibility requirements. The departments must submit a report to the general assembly by January 5, 2026, detailing their findings and proposed eligibility requirements for the medical assistance program and health insurance plans for public employees.